rare disease
Celemics, Strand Life Sciences Partner on Integrated Platform for NGS Analysis
Strand will integrate the Celemics bioinformatics pipeline into its StrandOmics analysis system to provide sample-to-report services to pharma and biotech researchers.
The German bioinformatics startup recently partnered with Genomics England and Genomenon as it seeks to accelerate and bring transparency to genetic testing processes.
EHR-Based Model Predicts Patients Who May Benefit from Genetic Testing for Rare Disease
Researchers from Vanderbilt University Medical Center said their approach could systematize who undergoes testing and shorten diagnostic odysseys.
Genomenon, Nostos Genomics to Integrate Technologies to Improve Rare Disease Dx
Genomenon will embed its Mastermind genomic search engine into the AI-driven Nostos AIon variant interpretation platform to power clinical decision support.
Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery
Premium
Fresh off a $13 million round of venture capital, the company said it sees global potential in analyzing hereditary conditions.